2026-2030年全球細胞健康篩檢市場

全球細胞健康篩檢市場預計將從 2025 年到 2030 年成長至 44.2 億美元，預測期內複合年成長率為 17.3%。

這份關於全球細胞健康篩檢市場的報告提供了全面的分析，包括市場規模和預測、趨勢、成長促進因素、挑戰以及涵蓋約 25 家供應商的供應商分析。

本報告對當前市場狀況、最新趨勢和促進因素以及整體市場環境進行了最新分析。推動該市場成長的因素包括：全球向預防醫學和長壽理念的轉變、多體學和高通量診斷技術的整合、慢性病盛行率的上升以及日益加劇的環境壓力。

本研究客觀地結合了一手和二手資料，包括來自主要行業相關人員的信息。報告內容涵蓋主要公司分析、全面的市場規模數據、區域細分分析以及供應商格局。報告還包含歷史數據和預測數據。

本研究指出，面向消費者的家用篩檢盒的普及是未來幾年全球細胞健康篩檢市場成長的主要驅動力之一。此外，人工智慧在細胞多組體學分析中的應用以及細胞篩檢在企業健康計畫中的整合，預計也將帶來顯著的市場需求。

目錄

第1章執行摘要

第2章 Technavio 分析

• 分析價格敏感度、生命週期、顧客購買籃子、採用率和購買標準。
• 輸入的重要性及差異化因素
• 干擾因素
• 促進因素和挑戰的影響

第3章 市場狀況

• 市場生態系統
• 市場特徵
• 價值鏈分析

第4章 市場規模

• 市場的定義
• 市場區隔分析
• 2025年市場規模
• 市場展望，2025-2030年

第5章 市場規模與表現

• 2020-2024年全球細胞健康篩檢市場
• 2020-2024年基於通路的細分市場分析
• 按類型分類的細分市場分析，2020-2024 年
• 2020-2024年基於技術的細分市場分析
• 區域區隔市場分析，2020-2024 年
• 2020-2024年各國細分市場分析

第6章 定性分析

• 人工智慧的影響：全球細胞健康篩檢市場
• 地緣政治衝突對全球細胞健康篩檢市場的影響。

第7章：五力分析

第8章 市場區隔：按通路

• 比較：按頻道
• 辦公室
• 醫院
• 診斷實驗室
• 家
• 其他
• 市場機會：按通路分類

第9章 市場細分：依類型

• 比較：按類型
• 單項測試板
• 多重測試面板
• 市場機會：按類型分類

第10章 市場區隔：依技術分類

• 比較：按技術
• qPCR,PCR
• 流式細胞技術
• ELISA
• NGS
• 其他
• 市場機會：依技術分類

第11章 客戶情況

第12章 區域情勢

• 區域細分
• 區域比較
• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 荷蘭
• 亞洲
  • 中國
  • 日本
  • 印度
  • 韓國
  • 印尼
  • 泰國
• 世界其他地區（RoW）
  • 巴西
  • 沙烏地阿拉伯
  • UAE
  • 阿根廷
  • 南非
  • 土耳其
  • 哥倫比亞
  • 以色列
• 市場機會：按地區分類

第13章 促進因素、挑戰與機遇

• 市場促進因素
• 市場挑戰
• 促進因素和挑戰的影響
• 市場機遇

第14章 競爭格局

• 概述
• 競爭格局
• 混亂局面
• 產業風險

第15章 競爭分析

• 公司簡介
• 公司排名指標
• 企業市場定位
• Agilent Technologies Inc.
• ARUP Laboratories
• BGI Genomics Co. Ltd.
• Cell Science Systems Corp.
• Creative Bioarray
• Fulgent Genetics Inc.
• Genova Diagnostics Inc.
• Laboratory Holdings Inc.
• Life Length SL
• Macrogen Inc.
• Quest Diagnostics Inc.
• Sonic Healthcare Ltd.
• SpectraCell Laboratories Inc.
• SYNLAB International GmbH
• TruDiagnostic LLC

第16章附錄

The global cellular health screening market is forecasted to grow by USD 4400.2 mn during 2025-2030, accelerating at a CAGR of 17.3% during the forecast period. The report on the global cellular health screening market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing global shift toward preventive healthcare and longevity, integration of multi-omics and high-throughput diagnostic panels, rising prevalence of chronic diseases and environmental stressors.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global cellular health screening market is segmented as below:

By Channel

• Office
• Hospital
• Diagnostic labs
• Home
• Others

By Type

• Single test panels
• Multi test panels

By Technology

• qPCR and PCR
• Flow cytometry
• ELISA
• NGS
• Others

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the expansion of direct-to-consumer at-home collection screening kits as one of the prime reasons driving the global cellular health screening market growth during the next few years. Also, incorporation of ai into cellular multi-omic analytics and integration of cellular screening into corporate wellness programs will lead to sizable demand in the market.

The report on the global cellular health screening market covers the following areas:

• Global cellular health screening market sizing
• Global cellular health screening market forecast
• Global cellular health screening market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global cellular health screening market vendors that include Agilent Technologies Inc., ARUP Laboratories, BGI Genomics Co. Ltd., Cell Science Systems Corp., Creative Bioarray, Epimorphy LLC, Fagron Genomics S.L.U., Fulgent Genetics Inc., Genova Diagnostics Inc., Laboratory Holdings Inc., Life Length SL, Macrogen Inc., NutriPATH Pty Ltd, Quest Diagnostics Inc., Repeat Diagnostics Inc., Sonic Healthcare Ltd., SpectraCell Laboratories Inc., SYNLAB International GmbH, TeloNostiX Ltd, TruDiagnostic LLC. Also, the global cellular health screening market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Channel
  • Executive Summary - Chart on Market Segmentation by Type
  • Executive Summary - Chart on Market Segmentation by Technology
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Cellular Health Screening Market 2020 - 2024
  • Historic Market Size - Data Table on Global Cellular Health Screening Market 2020 - 2024 ($ million)
• 5.2 Channel segment analysis 2020 - 2024
  • Historic Market Size - Channel Segment 2020 - 2024 ($ million)
• 5.3 Type segment analysis 2020 - 2024
  • Historic Market Size - Type Segment 2020 - 2024 ($ million)
• 5.4 Technology segment analysis 2020 - 2024
  • Historic Market Size - Technology Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on global cellular health screening market
• 6.2 Impact of geopolitical conflicts on global cellular health screening market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Channel

• 8.1 Market segments
• 8.2 Comparison by Channel
• 8.3 Office - Market size and forecast 2025-2030
• 8.4 Hospital - Market size and forecast 2025-2030
• 8.5 Diagnostic labs - Market size and forecast 2025-2030
• 8.6 Home - Market size and forecast 2025-2030
• 8.7 Others - Market size and forecast 2025-2030
• 8.8 Market opportunity by Channel
  • Market opportunity by Channel ($ million)

9 Market Segmentation by Type

• 9.1 Market segments
• 9.2 Comparison by Type
• 9.3 Single test panels - Market size and forecast 2025-2030
• 9.4 Multi test panels - Market size and forecast 2025-2030
• 9.5 Market opportunity by Type
  • Market opportunity by Type ($ million)

10 Market Segmentation by Technology

• 10.1 Market segments
• 10.2 Comparison by Technology
• 10.3 qPCR and PCR - Market size and forecast 2025-2030
• 10.4 Flow cytometry - Market size and forecast 2025-2030
• 10.5 ELISA - Market size and forecast 2025-2030
• 10.6 NGS - Market size and forecast 2025-2030
• 10.7 Others - Market size and forecast 2025-2030
• 10.8 Market opportunity by Technology
  • Market opportunity by Technology ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Europe - Market size and forecast 2025-2030
  • 12.4.1 Germany - Market size and forecast 2025-2030
  • 12.4.2 UK - Market size and forecast 2025-2030
  • 12.4.3 France - Market size and forecast 2025-2030
  • 12.4.4 Italy - Market size and forecast 2025-2030
  • 12.4.5 Spain - Market size and forecast 2025-2030
  • 12.4.6 The Netherlands - Market size and forecast 2025-2030
• 12.5 Asia - Market size and forecast 2025-2030
  • 12.5.1 China - Market size and forecast 2025-2030
  • 12.5.2 Japan - Market size and forecast 2025-2030
  • 12.5.3 India - Market size and forecast 2025-2030
  • 12.5.4 South Korea - Market size and forecast 2025-2030
  • 12.5.5 Indonesia - Market size and forecast 2025-2030
  • 12.5.6 Thailand - Market size and forecast 2025-2030
• 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 12.6.1 Brazil - Market size and forecast 2025-2030
  • 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.3 UAE - Market size and forecast 2025-2030
  • 12.6.4 Argentina - Market size and forecast 2025-2030
  • 12.6.5 South Africa - Market size and forecast 2025-2030
  • 12.6.6 Turkey - Market size and forecast 2025-2030
  • 12.6.7 Colombia - Market size and forecast 2025-2030
  • 12.6.8 Israel - Market size and forecast 2025-2030
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Growing global shift toward preventive healthcare and longevity
  • Integration of multi-omics and high-throughput diagnostic panels
  • Rising prevalence of chronic diseases and environmental stressors
• 13.2 Market challenges
  • Complex regulatory validation pathways and diagnostic standardization deficits
  • Biological sample degradation and cold chain logistics constraints
  • Data privacy vulnerabilities and consumer trust deficits
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Expansion of direct-to-consumer at-home collection screening kits
  • Incorporation of AI into cellular multi-omic analytics
  • Integration of cellular screening into corporate wellness programs

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Agilent Technologies Inc.
  • Agilent Technologies Inc. - Overview
  • Agilent Technologies Inc. - Business segments
  • Agilent Technologies Inc. - Key news
  • Agilent Technologies Inc. - Key offerings
  • Agilent Technologies Inc. - Segment focus
  • SWOT
• 15.5 ARUP Laboratories
  • ARUP Laboratories - Overview
  • ARUP Laboratories - Product / Service
  • ARUP Laboratories - Key offerings
  • SWOT
• 15.6 BGI Genomics Co. Ltd.
  • BGI Genomics Co. Ltd. - Overview
  • BGI Genomics Co. Ltd. - Product / Service
  • BGI Genomics Co. Ltd. - Key offerings
  • SWOT
• 15.7 Cell Science Systems Corp.
  • Cell Science Systems Corp. - Overview
  • Cell Science Systems Corp. - Product / Service
  • Cell Science Systems Corp. - Key offerings
  • SWOT
• 15.8 Creative Bioarray
  • Creative Bioarray - Overview
  • Creative Bioarray - Product / Service
  • Creative Bioarray - Key offerings
  • SWOT
• 15.9 Fulgent Genetics Inc.
  • Fulgent Genetics Inc. - Overview
  • Fulgent Genetics Inc. - Product / Service
  • Fulgent Genetics Inc. - Key offerings
  • SWOT
• 15.10 Genova Diagnostics Inc.
  • Genova Diagnostics Inc. - Overview
  • Genova Diagnostics Inc. - Product / Service
  • Genova Diagnostics Inc. - Key offerings
  • SWOT
• 15.11 Laboratory Holdings Inc.
  • Laboratory Holdings Inc. - Overview
  • Laboratory Holdings Inc. - Business segments
  • Laboratory Holdings Inc. - Key offerings
  • Laboratory Holdings Inc. - Segment focus
  • SWOT
• 15.12 Life Length SL
  • Life Length SL - Overview
  • Life Length SL - Product / Service
  • Life Length SL - Key offerings
  • SWOT
• 15.13 Macrogen Inc.
  • Macrogen Inc. - Overview
  • Macrogen Inc. - Product / Service
  • Macrogen Inc. - Key offerings
  • SWOT
• 15.14 Quest Diagnostics Inc.
  • Quest Diagnostics Inc. - Overview
  • Quest Diagnostics Inc. - Business segments
  • Quest Diagnostics Inc. - Key offerings
  • Quest Diagnostics Inc. - Segment focus
  • SWOT
• 15.15 Sonic Healthcare Ltd.
  • Sonic Healthcare Ltd. - Overview
  • Sonic Healthcare Ltd. - Business segments
  • Sonic Healthcare Ltd. - Key offerings
  • Sonic Healthcare Ltd. - Segment focus
  • SWOT
• 15.16 SpectraCell Laboratories Inc.
  • SpectraCell Laboratories Inc. - Overview
  • SpectraCell Laboratories Inc. - Product / Service
  • SpectraCell Laboratories Inc. - Key offerings
  • SWOT
• 15.17 SYNLAB International GmbH
  • SYNLAB International GmbH - Overview
  • SYNLAB International GmbH - Product / Service
  • SYNLAB International GmbH - Key offerings
  • SWOT
• 15.18 TruDiagnostic LLC
  • TruDiagnostic LLC - Overview
  • TruDiagnostic LLC - Product / Service
  • TruDiagnostic LLC - Key offerings
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations